Secukinumab and Bimekizumab for Hidradenitis Suppurativa

Поділитися
Вставка
  • Опубліковано 9 чер 2024
  • Check out the full article on HCPLive: www.hcplive.com/view/secukinu...
    Patients with HS are getting a long-awaited influx of targeted therapies. Jennifer L. Hsiao, MD, discusses their immediate impact.
  • Наука та технологія

КОМЕНТАРІ •